When Chander Dutt, a 60-year-old resident of Delhi, underwent a corneal transplant surgery on February 9 this year, he became the 100th beneficiary of a unique and ambitious mission launched in June 2010 by the Tej Kohli Foundation. Sonny Abraham of N…
Month: March 2011
New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma
Diopsys, Inc. has launched the new Diopsys® NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders.
New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma
Diopsys, Inc. has launched the new Diopsys® NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders.
Second Lucentis Phase III Study Meets Primary Endpoint For Improved Vision In Patients With Diabetic Macular Edema (DME)
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the second of two Phase III trials evaluating Lucentis® (ranibizumab injection) in patients with diabetic macular edema (DME) met its primary endpoint…
Abbott Introduces Micro-Implantation Cataract Suite
Abbott announced today that it has introduced a Micro-Implantation Cataract Suite designed to help improve cataract procedure outcomes and safety.
Abbott Introduces Micro-Implantation Cataract Suite
Abbott announced today that it has introduced a Micro-Implantation Cataract Suite designed to help improve cataract procedure outcomes and safety.
Will We Hear The Light? Infrared Can Activate Ear Cells
University of Utah scientists used invisible infrared light to make rat heart cells contract and toadfish inner-ear cells send signals to the brain. The discovery someday might improve cochlear implants for deafness and lead to devices to restore visio…
Genentech’s Lucentis Phase III trials in DME meets primary endpoints
Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.
The Development of Femtosecond Lasers for Cataract Surgery
Several years ago, in October 2008, I came across a writeup in Cataract & Refractive Surgery Today (CRST), about Technolas Perfect Vision announcing that the newly formed company would be using femtosecond laser technology to investigate laser-base…
FDA Approves Hyperopia Application For The MEL 80 Excimer Laser From Carl Zeiss Meditec
Carl Zeiss Meditec, Inc. announced today that the MEL 80 Excimer Laser has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the treatment of hyperopia. This new indication complements the existing FDA approved appl…
New Drugs, Laser Applications In Glaucoma Pipeline Could Enhance Treatment Options
A new medical class, additions to an existing class and new laser applications could increase the therapeutic options for glaucoma treatment, a physician said here.
New Drugs, Laser Applications In Glaucoma Pipeline Could Enhance Treatment Options
A new medical class, additions to an existing class and new laser applications could increase the therapeutic options for glaucoma treatment, a physician said here.
Femtosecond-Assisted PK A Potential Replacement For Standard PK
Despite several disadvantages, femtosecond-assisted penetrating keratoplasty may eventually serve as a viable replacement for standard PK, a presenter said here.
Femtosecond-Assisted PK A Potential Replacement For Standard PK
Despite several disadvantages, femtosecond-assisted penetrating keratoplasty may eventually serve as a viable replacement for standard PK, a presenter said here.
Increased Iris Thickness and Association With Primary Angle Closure Glaucoma
Is there a connection between iris thickness and the development of primary angle closure glaucoma? The British Journal of Ophthalmology
NICE guidance on laser correction of refractive error following non-refractive ophthalmic surgery
Refractive errors include common conditions such as myopia (short-sightedness) and hyperopia (long-sightedness) which impede the accuracy of vision without spectacles or contact lenses. Laser surgery aims to establish visual accuracy by changing the sh…
Eye Development Error Found To Be The Cause Of Cataracts, Glaucoma
A Jackson Laboratory research team, working in collaboration with researchers at Brigham and Women’s Hospital and Harvard Medical School in Boston, show that RNA granules – key players in messenger RNA (mRNA) processing – can affect eye development, le…
Differences In Eye Movement Between British And Chinese Populations
The team, working with Sichuan University in Chengdu, China, investigated eye movements in Chinese and British people to further understanding of the brain mechanisms that control them and how they compare between different human populations…
Testing Alterations In Night Vision
Researchers from the Department of Optics of the University of Granada, belonging to the Laboratorio de Ciencias de la Vision y Aplicaciones, have developed a programme for testing alterations in night vision, and the tool required to implement it, whi…
SARcode’s SAR 1118 Phase 2 data against dry eye to be presented at ARVO meeting
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology Annual Meeting being held May 1–May 5, 2011, in Fort…